Evidence map›Paper›PMID 40018626›Full record

ArticleBMJ public health2024

Examining self-described policy-relevant evidence base for policymaking: an evidence map of COVID-19 literature.

Emelda E Chukwu, Katie Woolaston, Ricardo Kaufer, Alejandro Bortolus, Chad L Hewitt, Evangelina Schwindt, Temitope O Sogbanmu, Anne Schwenkenbecher, Hannah Rubin, Helena Slanickova and 3 more

Abstract read
In one paragraph

Article in BMJ public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Emelda E ChukwuCenter for Infectious Diseases Research, Microbiology Department, Nigerian Institute of Medical Research, Lagos, Nigeria.ORCID 0000-0002-3110-1678
Katie WoolastonSchool of Law, Queensland University of Technology, Brisbane, Queensland, Australia.
Ricardo KauferAcademy for Territorial Development in the Leibniz Association - ARL, Hannover, Lower Saxony, Germany.
Alejandro BortolusInstituto Patagónico para el Estudio de los Ecosistemas Continentales (IPEEC-CONICET), Puerto Madryn, Argentina.
Chad L HewittCentre for Biosecurity Research Analysis and Synthesis, Lincoln University, Lincoln, New Zealand.
Evangelina SchwindtInstituto de Biología de Organismos Marinos (IBIOMAR-CONICET), Puerto Madryn, Argentina.
Temitope O SogbanmuEcotoxicology and Conservation Unit, Department of Zoology, Faculty of Science, University of Lagos, Akoka, Lagos, Nigeria.
Anne SchwenkenbecherCentre for Biosecurity and One Health, Murdoch University, Perth, Western Australia, Australia.
Hannah RubinDepartment of Philosophy, University of Missouri, Columbia, Missouri, USA.
Helena SlanickovaFaculty of Philosophy, University of Groningen, Groningen, The Netherlands.
Mike D SchneiderDepartment of Philosophy, University of Missouri, Columbia, Missouri, USA.
Remco HeesenDepartment of Philosophy, Logic and Scientific Method, London School of Economics and Political Science Methodology Institute, London, UK.
Veli MitovaAfrican Centre for Epistemology and Philosophy of Science, University of Johannesburg, Auckland Park, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Evidence-based policymaking is a paradigm aimed at increasing the use of evidence by actors involved in policymaking processes. The COVID-19 pandemic highlighted a heavy reliance on emerging evidence for policymaking during emergencies. Objective: This study describes the focus and types of evidence in journal articles self-described as relevant to policymaking using the COVID-19 pandemic as a case study, identifying gaps in evidence and highlighting author stated perceived biases specifically in evidence-based policy making. Design: Evidence mapping. Data sources: We systematically searched SCOPUS, PubMed and LexisNexis for literature identifying policy-relevant evidence available on the COVID-19 pandemic. Eligibility criteria: The study included only peer-reviewed literature identified as 'article', 'book chapter', 'review' covering the period from January 2020 to December 2022. Inclusion criteria required that articles have an abstract, authorship attribution and are written in English. Data extraction and synthesis: A minimum of two authors independently extracted and coded for every level and final outputs were compared for consistency. Results: A total of 213 articles met the inclusion criteria and were reviewed in this study. Lead authorship affiliations were from 50 countries with 70% of the outputs from developed economies including USA (20.2%), UK (18.3%) and Australia (7.5%). The most common purpose of the articles was the presentation of research findings the authors considered of relevance to policy (60.1%), followed by work that examined the impact of policy (28.6%) or highlighted or supported a policy need (22.5%), while some papers had multiple stated purposes. The most common challenges in policymaking identified by the authors of the reviewed papers were Conclusions: The evidence map identified the need for an interdisciplinary policy approach involving relevant stakeholders and driven by quality research as a progressive step towards prevention of future public health crises/pandemics.

Indexed as

COVID-19Public HealthSARS-CoV-2Zoonoses

Identifiers

PMID40018626
PMCPMC11816338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.